| Page 1067 | Kisaco Research
 

Harold Kolmar

Professor and Head, Institute for Organic Chemistry and Biochemistry
Technische Universität Darmstadt

Harold Kolmar

Professor and Head, Institute for Organic Chemistry and Biochemistry
Technische Universität Darmstadt

Harold Kolmar

Professor and Head, Institute for Organic Chemistry and Biochemistry
Technische Universität Darmstadt
 

Ken Howard

Assistant Professor
Aarhus University

Ken Howard

Assistant Professor
Aarhus University

Ken Howard

Assistant Professor
Aarhus University
 

Jeanette Leusen

Head of the Immunotherapy Group and UMAB
UMCU

Jeanette Leusen

Head of the Immunotherapy Group and UMAB
UMCU

Jeanette Leusen

Head of the Immunotherapy Group and UMAB
UMCU
 

Regis Cebe

Principal Scientist II
Novartis

Regis Cebe

Principal Scientist II
Novartis

Regis Cebe

Principal Scientist II
Novartis
 

David Eisen

Head of Analytical Development
Pieris Pharmaceuticals

David Eisen

Head of Analytical Development
Pieris Pharmaceuticals

David Eisen

Head of Analytical Development
Pieris Pharmaceuticals
 

Roberto De Luca

Head of Therapeutic Antibodies
Philogen

Roberto De Luca

Head of Therapeutic Antibodies
Philogen

Roberto De Luca

Head of Therapeutic Antibodies
Philogen
 

Claudio Sustmann

Senior Leader, Antibody Discovery & External Innovation, Large Molecules Research
Roche

Claudio Sustmann

Senior Leader, Antibody Discovery & External Innovation, Large Molecules Research
Roche

Claudio Sustmann

Senior Leader, Antibody Discovery & External Innovation, Large Molecules Research
Roche
 

Qian Zhang

Global Head of Lead Evalution and Protein Science
HiFiBio Therapeutics

Qian Zhang

Global Head of Lead Evalution and Protein Science
HiFiBio Therapeutics

Qian Zhang

Global Head of Lead Evalution and Protein Science
HiFiBio Therapeutics
 

Stephen Harper

Associate Director, Protein Engineering Research
Immunocore

Stephen Harper

Associate Director, Protein Engineering Research
Immunocore

Stephen Harper

Associate Director, Protein Engineering Research
Immunocore
 

Pauline Van Helden

Director, Translational Research
LAVA Therapeutics

Pauline Van Helden

Director, Translational Research
LAVA Therapeutics

Pauline Van Helden

Director, Translational Research
LAVA Therapeutics